Elevance Health Inc.ELVNYSE
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-23.34%
↓ 139% below average
Average (39q)
59.80%
Historical baseline
Range
High:1333.17%
Low:-88.90%
CAGR
-2.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -23.34% |
| Q2 2025 | -18.06% |
| Q1 2025 | 361.55% |
| Q4 2024 | -55.86% |
| Q3 2024 | -54.02% |
| Q2 2024 | 1.60% |
| Q1 2024 | 193.61% |
| Q4 2023 | -39.48% |
| Q3 2023 | -32.24% |
| Q2 2023 | -6.80% |
| Q1 2023 | 126.95% |
| Q4 2022 | -45.75% |
| Q3 2022 | 0.24% |
| Q2 2022 | -7.98% |
| Q1 2022 | 64.71% |
| Q4 2021 | -29.86% |
| Q3 2021 | -15.17% |
| Q2 2021 | 8.13% |
| Q1 2021 | 256.14% |
| Q4 2020 | 57.07% |
| Q3 2020 | -87.65% |
| Q2 2020 | 50.74% |
| Q1 2020 | 90.26% |
| Q4 2019 | -26.26% |
| Q3 2019 | 2.48% |
| Q2 2019 | -25.30% |
| Q1 2019 | 258.20% |
| Q4 2018 | -56.28% |
| Q3 2018 | -17.42% |
| Q2 2018 | -15.51% |
| Q1 2018 | 1333.17% |
| Q4 2017 | -88.90% |
| Q3 2017 | -7.19% |
| Q2 2017 | -20.42% |
| Q1 2017 | 130.03% |
| Q4 2016 | -42.05% |
| Q3 2016 | -21.53% |
| Q2 2016 | 10.39% |
| Q1 2016 | 250.52% |
| Q4 2015 | -66.86% |